Minimum Advertised Price (MAP) Policy in Medical Distribution

A Minimum Advertised Price (MAP) policy is a manufacturer’s rule that sets a floor on the price a distributor or reseller is allowed to publish or display publicly for that manufacturer’s product — on a website, in a printed catalog, in a mass email, or in any other advertisement a general audience can see. It does not set a floor on the price the reseller actually charges. Those two numbers are frequently different, and the gap between them is the single most common source of confusion buyers run into with MAP.

What MAP actually restricts

MAP governs advertising, not transactions. If a manufacturer sets MAP at $4,200 for an analytical instrument, a distributor cannot list “$3,600” on its public product page, in a PDF catalog, or in a promotional email — doing so is an advertised-price violation the manufacturer can enforce (typically by suspending the distributor’s ability to sell that line, not by suing over price). But nothing in that same MAP policy stops the distributor from privately quoting, negotiating, or invoicing a buyer at $3,600, or lower, as long as that number is never displayed publicly. A buyer who only looks at the advertised price and assumes it is non-negotiable is reading a MAP floor as if it were a contract floor, which it is not.

Why a buyer sees one number and pays another

This is a genuinely common point of confusion in medical and lab-equipment procurement specifically, because institutional buying already runs on a two-tier pricing structure for unrelated reasons: list price versus contract price. A distributor’s public-facing price (constrained by MAP, if the manufacturer sets one) is effectively that distributor’s list price. A buyer covered by a Group Purchasing Organization (GPO) contract, a direct manufacturer agreement, or simply a negotiated institutional account can be quoted a contract price below the advertised MAP figure through a private channel — a sales rep, a password-gated buyer portal, a formal quote — without the distributor doing anything improper. The advertised number and the number on the purchase order are allowed to diverge; MAP only ever governs the first one.

What MAP does not restrict

• Private quotes and negotiated contract pricing. A quote sent directly to one buyer, not visible to the general public, sits outside MAP’s scope regardless of how far below the advertised price it goes.
• What actually appears on the invoice. The transaction price a facility is billed is a separate number from the advertised price, and MAP has no authority over it.
• Rebates and chargebacks settled after the sale. A distributor can sell at (or above) MAP publicly and still pass savings back to the buyer through a rebate or chargeback mechanism that never appears in the advertisement itself.

MAP also is not a resale price maintenance rule. A manufacturer that dictated the actual price a reseller must charge would be attempting genuine price-fixing, which raises real antitrust exposure. A MAP policy is deliberately narrower: it is a unilateral advertising restriction the manufacturer enforces by declining to keep supplying resellers who ignore it, not a price the manufacturer sets by contract or coercion — the distinction (in the U.S., traced to the long-standing Colgate doctrine on unilateral pricing policies) is exactly what keeps a MAP policy on the legal side of that line, and exactly why it can only ever reach what gets advertised, never what gets charged.

Worked examples

Example 1. A lab-equipment distributor’s public website lists a benchtop centrifuge at “$4,200 (MAP)” with an “add to cart” flow but no visible discount. A hospital’s materials-management team, covered by a GPO contract for lab equipment, requests a formal quote through the distributor’s institutional sales channel and receives a written quote of $3,050 for the same model — a price never displayed anywhere public. Both the $4,200 advertised figure and the $3,050 contract price are legitimate at the same time; the buyer who only checked the website would have assumed $4,200 was the real price.

Example 2. A distributor runs a public promotional email campaign advertising “10% off list on all centrifuges this month,” which would put the advertised price below the manufacturer’s MAP floor. The manufacturer flags the campaign and the distributor pulls it, but continues privately quoting the same discounted net price to any buyer who calls or requests a quote — that private channel was never restricted by MAP in the first place, only the public email was.

Counter-example

A distributor’s sales rep discloses a specific discounted price in a public webinar chat, in a public online forum thread, or on a public-facing live-chat widget visible to any site visitor (not a gated institutional login) — this is not a private quote even though it feels like one-to-one communication, because the channel itself is publicly visible. If that number is below the manufacturer’s MAP, it is a MAP violation regardless of the informal setting, because MAP scope turns on public visibility of the price, not on the format of the conversation.

Related terms

See also contract price vs. list price, Group Purchasing Organization (GPO), chargeback, and volume discount tiers vs. rebate programs for the other mechanisms that separate a medical-supply distributor’s public price from what an institutional buyer actually pays.